Reveal HealthTech, an AI healthcare startup, has raised $7.2 million in its Series A funding round led by Leo Capital with participation from Sanos Capital.
The fresh funds raised will be used to expand its capabilities and solutions, strengthen its sales network, and extend its reach to more healthcare and life sciences leaders worldwide.
Founded in 2023 by Sanchit Mullick and incubated by W Health Ventures and 2070 Health, Reveal HealthTech provides specialized engineering, clinical model, and strategy support to healthcare organizations.
Reveal helps healthcare organizations identify their most valuable problems and build safe, clinically relevant systems to solve them.
Reveal’s solutions focus on driving customer value and improving the profitability of healthcare operations. Its flagship offerings include BioCanvas, which enables multimodal AI use cases such as speeding up clinical trial recruitment using AI, and Prism AI for rapid development of intelligent agents for workflow automation.
Sanchit Mullick, Founder of Reveal HealthTech, said, “Our mission is simple but bold. We want to make AI the most trusted and accountable partner in healthcare, driving breakthroughs for everyone from Fortune 100 pharma companies and large healthcare delivery systems to emerging innovators in digital health.”
Rajul Garg, Partner, Leo Capital, said, “Meeting with Sanchit, Dr Salim, and the AI leadership team at Reveal made it clear their superpower lies in crafting tailored solutions that demonstrate time-bound, business goodness to clients. We’re very excited to support the team in its next phase of growth.”
Dr. Pankaj Jethwani, Managing Partner at W Health Ventures, said, “Healthcare cannot be solved with one-size-fits-all point solutions. Reveal understands that nuance, which is why we backed them from day one. We see an incredible opportunity for Reveal to support the rapid AI adoption within the US healthcare industry.”
